Forward Industries, Inc. - 10-K Summary (Fiscal Year Ended Sept 30, 2009)
Business Context and Reporting Period
Forward Industries, Inc. designs, markets, and distributes carry solutions (cases, bags, clips) for handheld electronic devices, primarily for Original Equipment Manufacturers (OEMs). The company does not manufacture products but sources them from independent suppliers, predominantly in Asia. This report covers the fiscal year ended September 30, 2009. The company is classified as a smaller reporting company.
Key Financial Metrics
| Metric | Fiscal 2009 | Fiscal 2008 |
|---|---|---|
| Net Sales | $17.44 million | $19.97 million |
| Gross Profit | $3.58 million | $4.03 million |
| Gross Margin | 21% | 20% |
| Operating Expenses | $4.93 million | $5.69 million |
| Net Loss | ($1.39 million) | ($0.89 million) |
| Loss Per Share (Basic/Diluted) | ($0.18) | ($0.11) |
| Cash and Cash Equivalents | $20.10 million | $19.86 million |
| Working Capital | $22.3 million | $23.1 million |
| Current Ratio | 12.4 | 10.6 |
| Debt | $0 | $0 |
Note: The company has no short-term or long-term debt outstanding. Liquidity is supported by significant cash reserves.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 13% ($2.5 million) primarily due to a 15% drop in Diabetic Product sales ($2.3 million decline). Sales of "Other Products" (including cell phone accessories) declined 6%.
- Increased Net Loss: The net loss widened by $0.5 million. This was driven by a $0.3 million income tax expense (vs. a benefit in 2008) resulting from a full valuation allowance on deferred tax assets, lower gross profit, and reduced interest income.
- Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased 13% ($0.76 million) due to reduced personnel costs following executive contract expirations and lower royalty/commission expenses.
- Customer Concentration: The top three customers accounted for 66% of net sales in 2009, down from 75% in 2008. However, reliance on the Diabetic Products line remains high at 75% of total sales.
Outlook, Risks, and Management Commentary
- Strategic Shift: Management is actively pursuing business diversification through acquisition or investment due to the decline in cell phone accessory sales and the economic downturn affecting OEM customers.
- Cost Pressures: The company faces pricing pressure from OEMs seeking cost reductions, while simultaneously facing inflationary pressures on supply costs and currency fluctuations (Renminbi appreciation) that may compress gross margins in Fiscal 2010.
- Key Risks:
- Concentration Risk: High dependence on three major OEM customers for diabetic monitoring kits; loss of any one could materially impact operations.
- Supply Chain: Reliance on foreign suppliers (90% from seven suppliers, 54% from one) creates risks regarding quality, delivery, and currency exchange.
- Market Conditions: Continued global recession and OEM decisions to eliminate "in-box" accessories could further reduce revenue.
- Subsequent Event: In November 2009, the company terminated its corporate headquarters lease in Florida to reduce costs, paying a $55,000 termination fee and subleasing a portion of the space.
Investor Verification Checklist
- Customer Retention: Verify the status of contracts with the top three customers (representing 66% of sales) and any indications of order reductions for Fiscal 2010.
- Acquisition Progress: Confirm if any specific acquisition targets have been identified or if the search for diversification has yielded concrete opportunities.
- Margin Sustainability: Assess the ability to pass on rising supplier costs and currency impacts to customers without losing volume.
- Cash Utilization: Monitor the deployment of the $20 million cash balance, specifically regarding potential M&A activity or continued cost-cutting measures.
- Deferred Tax Assets: Review future projections for taxable income to determine if the full valuation allowance on deferred tax assets ($0.6 million) can be reversed.